

























































Acta Derm Venereol 2021; 101: adv00369
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta doi: 10.2340/00015555-3707
Society for Publication of Acta Dermato-Venereologica
SIGNIFICANCE
The control of cutaneous microbiota-induced immune ac-
tivation in keratinocytes is key to the maintenance of epi-
dermal homeostasis. Tumour necrosis factor alpha-induced 
protein 3, a regulator of nuclear factor kappa B signalling 
pathways, has important roles in these processes. It forms 
a negative regulatory feedback loop, controls the activity 
of toll-like receptor-induced signalling pathways, but is also 
regulated by different toll-like receptor ligands and by Cuti-
bacterium acnes, a member of our skin microbiota. The 
levels of tumour necrosis factor alpha-induced protein 3 
greatly influence levels of bacterium-induced inflammatory 
mediators in keratinocytes. This study found elevated ex-
pression of tumour necrosis factor alpha-induced protein 
3 mRNA in acne lesions. These findings suggest a general 
role of tumour necrosis factor alpha-induced protein 3, not 
only in the regulation of toll-like receptor-induced immune 
activation, but also in cutaneous immune homeostasis.
Human epidermal keratinocytes sense the presence 
of human skin microbiota through pathogen recogni-
tion receptors, such as toll-like receptors, and induce 
innate immune and inflammatory events. In healthy 
epidermis there is an absence of inflammation despite 
the continuous presence of cutaneous microbes, which 
is evidence of an effective immune regulatory mecha-
nism. The aim of this study was to investigate tumour 
necrosis factor alpha-induced protein 3 (TNFAIP3), 
a negative regulator of toll-like receptor and nuclear 
factor kappa B signalling pathways, and its role in 
these regulatory events. A broad spectrum of toll- 
like receptor ligands induced TNFAIP3 expression, as 
did live Cutibacterium acnes, which is involved in the 
pathogenesis of acne. Changes in bacterium-induced, 
dose-dependent TNFAIP3 expression were Jun kinase- 
and nuclear factor kappa B-dependent, and resulted in 
altered cytokine and chemokine levels in in vitro cul-
tured human keratinocytes. In acne lesions, TNFAIP3 
mRNA expression was elevated compared with non-
lesional skin samples from the same individuals. These 
results suggest that TNFAIP3 may have a general role 
in fine regulation of microbiota-induced cutaneous im-
mune homeostasis.
Key words: TNFAIP3; microbiota; Cutibacterium acnes; acne 
vulgaris; innate immunity.
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The human skin separates the body from the external environment and plays a role in the formation of a 
complex physical, chemical and immunological barrier 
(1). The skin also provides a natural habitat for the cuta-
neous microbiota, a collection of microbial species living 
in close contact with human cells (2). Human epidermal 
keratinocytes are the major cellular components of skin 
and are in direct contact with these microbes. 
Keratinocytes are immunocompetent cells that can 
sense different external danger signals, known as pattern- 
and danger-associated molecular patterns (PAMPs and 
DAMPs), through their pattern recognition receptors 
(PRRs), such as toll-like receptors (TLRs). PAMPs and 
DAMPs originate from human and microbial cells and 
induce TLR activation, as well as subsequent activation 
of innate immune and inflammation responses in kerati-
nocytes (3, 4). In past decades, research efforts identified 
endogenous negative regulators of these signalling pat-
hways that are able to control these processes. One such 
molecule is tumour necrosis factor alpha-induced protein 
3 (TNFAIP3), also known as A20, which is a ubiquitin-
editing enzyme involved in the inhibition of nuclear factor 
kappa B (NF-κB) activation and tumour necrosis factor 
(TNF)-α-induced apoptosis (5).
In healthy skin, the presence of the cutaneous microbiota 
does not lead to excessive immune activation, even though 
the microbes express various PAMP molecules and are 
continuously present on the skin. Meanwhile, human cells 
must retain their capacity to respond to pathogenic micro-
organisms, necessitating complex regulation to maintain 
healthy body functions and homeostasis. Currently, little is 
known about the exact mechanisms by which keratinocytes 
are able to distinguish between pathogens and harmless 
members of the microbiota, tolerate the presence of resi-
dential microbes, or control the immune and inflammatory 
events that they are able to induce.
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Cutibacterium acnes (formerly known as Propionibac-
terium acnes) is a commensal bacterium that colonizes the 
upper part of the epidermis and the pilosebaceous units, 
where it becomes a dominant species during puberty (6, 7). 
Human epidermal keratinocytes recognize this bacterium 
via TLR2 and TLR4 (8, 9). Receptor activation leads to 
the induction of multiple signalling paths, including the 
NF-κB and mitogen-activated protein kinase (MAPK) pat-
hways, resulting in upregulation of several inflammatory 
mediators, which, in turn, promote local inflammation 
(10–12). Although immune events induced by commensal 
microbes are well characterized, especially for C. acnes, 
much less is known about the factors or signalling path-
ways that contribute to the negative regulation of these 
processes. Such processes are necessary to protect the 
host from the deleterious consequences of unnecessary 
inflammation. In a search for such factors, a recent study 
showed the potential role of TNFAIP3 in immune events 
induced by Staphylococcus epidermidis in keratinocytes 
(13). Based on these data, the aim of the current study was 
to determine whether the described negative regulatory 
function of TNFAIP3 is specific for processes induced by 
S. epidermidis, or whether TNFAIP3 has a more general 
role in controlling different TLR ligand-induced signal-
ling pathways in keratinocytes. This study also examined 
whether TNFAIP3 contributes to the control of other 
cutaneous microbes, by assessing its role in C. acnes-
induced inflammation. 
MATERIALS AND METHODS
Cell culture and models
The human immortalized keratinocyte cell line HPV-KER was 
used for this study. To generate the HPV-KER cell line, normal 
human adult keratinocytes (NHEK) were obtained from a healthy 
individual undergoing routine plastic surgery at the Department of 
Dermatology and Allergology, University of Szeged and transfec-
ted with the pCMV vector containing the HPV16/E6 oncogene. A 
stable cell line was established by continuous culturing over 70 
passages before the start of the experiments. Previously, we have 
shown, that HPV-KER cells respond to TLR stimuli, ( C. acnes, 
poly (I:C), poly (dA:dT)) similarly to NHEK cells (14–17).
Cells were cultured in keratinocyte serum-free medium (KSFM, 
Life Technologies, Carlsbad, CA, USA) containing 1% antibiotic/
antimycotic (AB/AM) solution (containing penicillin, streptomy-
cin, amphotericin B) (Sigma Aldrich, St Louis, MO, USA) and 
supplemented with epidermal growth factor and brain pituitary 
extract under standard laboratory conditions (37°C in a humidified 
atmosphere containing 5% v/v CO2).
Ex vivo skin biopsies were taken from skin specimens obtained 
from the plastic surgery unit of our department. Written informed 
consent was obtained from investigated individuals. The study 
was approved by the Human Investigation Review Board of 
the University of Szeged (PSO-EDAFN-002, 34/2015, 3517, 
23 February 2015, Szeged, Hungary) and the Medical Research 
Council Ethics Committee of Hungary (ETT-TUKEB 39361). The 
studies complied with the ethical standards of research and were 
in accordance with the principles of the Declaration of Helsinki. 
For ex vivo organotypic skin (OS) cultures, 1×1 cm biopsies were 
washed first with normal saline solution (NSS) containing 2% AB/
AM, followed by a wash with AB/AM-free NSS. Subsequently, the 
biopsies were placed onto the upper chamber of Transwell® Inserts 
(Corning, New York, USA) and kept at the air–liquid interphase. 
The dermal part of the biopsies was in contact with DMEM F12 
liquid culture medium (Lonza, Basel, Switzerland) supplemented 
with 10% FBS (EuroClone, Milan, Italy) lacking AB/AM.
Data analyses
TNFAIP3 gene expression was analysed using publicly available 
microarray data from the GEO Profile Database (GDS2478 da-
tasets, ID: 33444972), which compares the total RNA content of 
healthy skin (n = 6) with lesional (n = 6) and non-lesional (n = 6) 
samples from patients with acne (18).
Treatments
TLR1/2 (Pam3CSK4, 5 μg/ml), TLR2 (peptidoglycan, PGN, 10 
μg/ml), TLR3 (poly I:C, 20 μg/ml), TLR4 (lipopolysaccharide, 
LPS, 2.5 μg/ml), TLR5 (flagellin, FLA, 0.5 μg/ml) and TLR2/6 
(FSL-1, 1 μg/ml) ligands were applied to HPV-KER cells for 3, 
6, 12 and 24 h (all reagents from InvivoGen, Toulouse, France).
For bacterial treatment, HPV-KER cells were plated in AB/
AM-free KSFM culture medium and co-cultured with live C. 
acnes strains belonging to different phylogenetic groups within 
the species (889, I/A, ATCC 11828, II, 6609, I/B) at various 
multiplicity of infection (MOI). Ex vivo skin models were treated 
with the C. acnes 889 strain at a density of 3×107 colony forming 
units per cm2 for 24 h. C. acnes strains were cultured and stored, 
as described previously (19). 
The selective inhibitors of JNK (sp 600125, 10 μM), NF-κB 
(Bay 11-7085, 10 μM), p38 (sb 203580, 10 μM), ERK1/2 (PD 
098059, 20 μM), or, as a control, DMSO were applied to the cells 
for 1 h (all reagents from Sigma Aldrich, St Louis, MO, USA).
Transfection, plasmids and siRNA-mediated gene silencing
For transient siRNA-mediated gene silencing, siRNA was de-
livered by the Santa Cruz siRNA Transfection Reagent (Santa 
Cruz Biotechnology, TX, USA) according to the manufacturer’s 
instructions. ON-TARGETplus SMARTpool TNFAIP3 siRNA 
or ON-TARGETplus Non-targeting Pool (Dharmacon, Lafayette, 
CO, USA) constructs were used at 25 nM concentration. 
NF-κB luciferase reporter assay was performed using the Path-
Detect pNF-κB-Luc Cis-Reporter Plasmid (Stratagene, San Diego, 
CA, USA), pGL4.75[hRluc/CMV] vector, which was transfected 
with X-tremeGENE 9 DNA Transfection Reagent (Roche Diag-
nostics, Rotkreuz, Switzerland). For analysis, the Firefly & Renilla 
Dual Luciferase Assay Kit (Biotium Inc, Fremont, CA, USA) was 
used according to the manufacturer’s instructions.
Enzyme-linked immunosorbent assay
C. acnes-treated and control HPV-KER cell culture supernatants 
were collected and levels of secreted IL-8, IL-6 and CCL5 were mea-
sured by enzyme-linked immunosorbent assay (ELISA) (PeproTech 
EC Ltd, London, UK) according to the manufacturer’s instructions.
RNA isolation, cDNA synthesis and real-time RT-PCR
Total RNA from HPV-KER cells or the epidermal part of OS 
cultures were isolated using TRI-Reagent (Molecular Research 
Center; Cincinnati, USA). cDNA synthesis was performed using 
1 μg RNA with the iScript TM cDNA Synthesis kit (Bio-Rad, 
Hercules, CA, USA). Changes in mRNA expression were detected 
by real-time RT-PCR using the Universal Probe Library (Roche 
Diagnostics) or the TaqMan Gene Expression Assay (Thermo 
Scientific, Rockford, IL, USA). Table SI1 lists the PCR protocols 
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rRNA using the ΔΔCt method and compared with the time-matched 
untreated control samples.
Protein isolation and western blot analysis
For the preparation of whole cell lysates, samples were collected 
and lysed in lysis buffer containing 20 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulphonic acid, 150 mM KCl, 1 mM MgCl2, 
1 mM DTT, 5% Triton X-100, 10% glycerol, 0.1% NP-40, 1% 
Protease Inhibitor Cocktail, phenylmethylsulphonyl fluoride and 
0.5% SDS (all from Sigma Aldrich). Protein concentrations were 
measured with the BCA Protein Assay Kit (Thermo Scientific). 
Samples (30 μg) were separated on a 7.5% SDS-PAGE gel and 
transferred to nitrocellulose membrane (Bio-Rad), blocked in Tris-
buffered saline containing 5% non-fat dried milk. Membranes were 
incubated overnight at 4°C with primary anti-TNFAIP3 antibody 
diluted 1:1000 (Abcam, Cambridge, UK) and anti-actin (Sigma 
Aldrich) diluted 1:1000. Subsequently, membranes were incubated 
for 1 h at room temperature with a horseradish peroxidase-conjuga-
ted anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology 
diluted 1:2000. Proteins were visualized with luminol (Bio-Rad 
and Advansta Inc., CA, USA) using an Omega Lum™ G Imaging 
System (Gel Company, San Francisco, CA, USA) or C-digit blot 
scanner (LI-COR Biosciences, Lincoln, NE, USA).
Fluorescence microscopic analysis 
Frozen sections of ex vivo skin models were pre-incubated with PBS 
for 5 min, fixed with 4% paraformaldehyde for 5 min and permeabi-
lized with 0.25% TritonX-100 (Thermo Scientific, Rockford, USA) 
containing Tris-buffered saline (TBS) for 10 min. For blocking, TBS 
containing 5% foetal bovine serum (EuroClone, Milan, Italy) and 
5% normal goat serum (Sigma Aldrich, St Louis, MO, USA) was 
used for 1 h at room temperature. Cells were stained for 1 h with 
anti-human TNFAIP3 antibody diluted 1:300 or rabbit IgG (Santa 
Cruz Biotechnology) for isotype control. As a secondary antibody, 
Alexa Fluor 546 conjugated anti-rabbit IgG (Thermo Scientific) was 
used for 1 h at room temperature. Nuclei were stained for 5 min with 
4′,6-diamidino-2-phenylindole (DAPI) diluted 1:100. TNFAIP3 
was visualized using a ZEISS LSM 880 Confocal Laser Scanning 
Microscope (Zeiss, Oberkochen, Germany), magnification × 63.
Statistical analysis
Unless otherwise noted, all data are presented as mean ± standard 
error of the mean (SEM) of 3 independent experiments. For real-
time RT-PCR analyses and ELISA, each treatment was performed 
at least in triplicate; for western blot and fluorescence microscopic 
analysis, each treatment was performed once in every independent 
experiment. Data were compared using paired, 2-sample t-test 
with Holm–Bonferroni correction using R software, version 3.6.2 
(R-Studio, Boston, MA, USA). A p-value < 0.05 was considered 
significant.
RESULTS
TNFAIP3 expression changes upon TLR activation in 
keratinocytes
Keratinocytes are able to sense different PAMPs and 
DAMPs with their TLRs. This study investigated whether 
the activation of different TLRs using selected ligands 
influences TNFAIP3 expression of an in vitro cultured 
human keratinocyte cell line. HPV-KER cells were trea-
ted with Pam3CSK4 (TLR1/2), PGN (TLR2), poly I:C 
(TLR3), LPS (TLR4), FSL-1 (TLR5) and FLA (TLR2/6,) 
and TNFAIP3 mRNA and protein expression analysed 
with real-time RT-PCR and western blot analysis.
TNFAIP3 mRNA expression increased rapidly in re-
sponse to all the investigated TLR ligands. The intensity and 
kinetics of these changes varied and depended on the ligand 
used (Fig. 1A). TNFAIP3 protein expression levels also 
increased rapidly: elevated levels were detected 6 h after 
ligand treatment, and these levels remained high after 24 h 
(Fig. 1B). These results suggest that TNFAIP3 is a generally 
induced molecule upon TLR activation in keratinocytes.
Cutibacterium acnes increases TNFAIP3 expression in 
keratinocytes
To analyse whether C. acnes affects TNFAIP3 expression 
levels in keratinocytes, HPV-KER cells were co-cultured 
with the C. acnes 889 bacterium strain (MOI 100) and the 
mRNA and protein expression changes analysed with real-
time RT-PCR and western blot analysis. TNFAIP3 mRNA 
levels rapidly and transiently increased in the presence of 
the bacterium, reaching a maximum 12 h after bacterial 
treatment (Fig. 2A).
Various C. acnes strains may differentially affect the 
cellular and molecular properties of human keratinocytes 
(16, 19, 20). To analyse possible strain-specific regulation, 
the HPV-KER cells were co-cultured with different C. 
acnes strains (MOI=100) belonging to various phyloge-
netic groups within the species ( C. acnes 889 - IA, 6609 
- IB, ATCC 11828 - II) and compared their effects. All of 
the C. acnes strains used were able to induce TNFAIP3 
expression changes in HPV-KER cells. Slight differences 
were detected in the induction rates, but the kinetics of 
the expression changes appeared similar (Fig. S11). Based 
on these observations, the C. acnes 889 strain was used 
in subsequent experiments.
TNFAIP3 protein expression levels also increased ra-
pidly in response to the bacterium (MOI=100) (Fig. 2C) 
and remained high during the time-course of the study. 
This study also examined whether changes in C. acnes-
induced TNFAIP3 expression were dose-dependent, by co-
culturing HPV-KER cells with different MOIs. It was found 
that the extent of TNFAIP3 mRNA and protein expression 
changes depended on the bacterial dose (Fig. 2B, D). 
To confirm that the observed changes were not specific 
properties of the immortalized keratinocyte cell line used, 
the experiments were also performed with NHEK cells. 
Similar TNFAIP3 expression changes were found upon C. 
acnes treatment as those described in HPV-KER cells. C. 
acnes treatment resulted in elevated TNFAIP3 mRNA levels 
and dose-dependent protein expression changes (Fig. S21).
To further test TNFAIP3 inducibility in keratinocytes 
in the presence of C. acnes, ex vivo organotypic skin (OS) 
cultures were tested. In this model, normal epithelial tissue 
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is better preserved. OS cultures were treated with live 
C. acnes bacterium and changes in the mRNA expres-
sion were analysed using real-time RT-PCR. Levels of 
TNFAIP3 mRNA expression increased in the epidermis 
part of the OS cultures upon C. acnes treatment, similar 
to that observed in monolayer cultures (Fig. 2G). 
Earlier studies have shown that TNFAIP3 protein is 
expressed in the human epidermis (21). The current study 
confirmed this finding by immunofluorescence staining of 
OS cultures, in which the TNFAIP3 protein was present 
throughout the entire epidermis, especially in the most 
differentiated keratinocyte layers. Immunofluorescence 
microscopy analysis also revealed elevated TNFAIP3 
protein levels in response to C. acnes treatment (Fig. 2H).
Changes in C. acnes-induced TNFAIP3 expression are 
dependent on Jun kinase- and NF-κB signalling pathways 
This study also investigated the signalling mechanisms 
playing important roles in TNFAIP3 regulation. The di-
merization partner, RB-like, E2F and multi-vulval class 
B (DREAM) transcription complex is known to repress 
its transcription when bound to the DRE3 and DRE4 
elements in the TNFAIP3 promoter region in human lung 
microvessel endothelial cells (HLMVECs). The TNFAIP3 
promoter also harbours functional NF-κB binding sites 
(22, 23). To identify the possible signalling pathways 
involved in C. acnes-induced upregulation of TNFAIP3 
in keratinocytes, the current study investigated the contri-
bution of selected pathways playing important roles in 
the bacterium-induced signalling events (10–12). We 
inhibited the NF-κB and MAPK (JNK, p38 and ERK1/2) 
signalling pathways using specific inhibitors and analysed 
changes in TNFAIP3 mRNA and protein expression in 
HPV-KER cells after co-culturing the cells for 12 and 24 h 
with the C. acnes 889 strain.
This study found that inhibition of the JNK signalling pat-
hway decreased basal TNFAIP3 mRNA expression, where-
as C. acnes-induced mRNA levels were affected by JNK 
and NF-κB inhibition (Fig. 2E). Dual inhibition of these 
Fig. 1. mRNA and protein expression of tumour necrosis factor alpha-induced protein 3 (TNFAIP3) increases in response to toll-like 
receptor (TLR) activation. Human immortalized keratinocyte cell line (HPV-KER) cells were treated with different TLR ligands (Pam3CSK4, PGN, poly 
I:C, FLA, FSL-1). TNFAIP3 mRNA and protein levels were analysed at the indicated time-points. (A) Changes in TNFAIP3 mRNA expression analysed by 
real-time RT-PCR; data were normalized to 18S rRNA using the ΔΔCt method and compared with the time-match untreated control values. Error bars: 
standard error of the mean (SEM). (B) Changes in TNFAIP3 protein expression were analysed by western blot analysis and quantitated using Image Pro 
Plus (Media Cybernetics, Inc., Rockville, MD, USA); all data were normalized to actin. Statistical analyses: paired, 2-sample t-test with Holm–Bonferroni 
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2 signalling pathways almost completely prevented the 
bacterium-induced changes in mRNA expression (Fig. S31), 
suggesting that these 2 pathways play major roles in the 
transcriptional regulation of the TNFAIP3 locus. We also 
detected decreased protein levels upon JNK and NF-κB 
path way inhibition in the C. acnes-treated samples (Fig. 2F).
TNFAIP3 affects basal and C. acnes-induced levels of 
inflammatory mediators in keratinocytes
To analyse the role of TNFAIP3 in the regulation of key 
inflammatory mediators, siRNA-mediated silencing was 
performed. Silencing resulted in decreased TNFAIP3 
Fig. 2. Cutibacterium acnes upregulates the mRNA and protein expression of tumour necrosis factor alpha-induced protein 3 (TNFAIP3). 
(A–F) Human immortalized keratinocyte cell line (HPV-KER) cells and (G, H) organotypic skin (OS) were treated with C. acnes, and changes in TNFAIP3 
mRNA and protein levels were analysed. (A, B) mRNA expression was analysed by real-time RT-PCR; data were normalized to 18S rRNA and compared 
with the time-match untreated control values. Error bars: standard error of the mean (SEM). (C, D) TNFAIP3 protein expression was analysed by western 
blot and quantified using Image Pro Plus (Media Cybernetics, Inc., Rockville, MD, USA); all data were normalized to actin and compared with time-matched 
untreated control values. Statistical analyses: paired, 2-sample t-test with Holm–Bonferroni correction: *p < 0.05. (E, F) Cells were plated and pretreated 
with selective inhibitors for Jun kinase (JNK), nuclear factor kappa B (NF-κB), p38 and ERK1/2 or, as a control, Dimethyl sulphoxide (DMSO) for 1 h. 
For mRNA expression studies, C. acnes challenge was performed for 12 h and analysed by real-time RT-PCR. All data were normalized to the 18S rRNA 
and compared with DMSO-treated control samples. For protein expression analyses, cells were treated with C. acnes for 24 h, subjected to western blot 
analysis and quantified with Image Pro Plus; all data were normalized to actin and compared with time-matched untreated control values. Statistical 
analyses: paired, 2-sample t-test with Holm–Bonferroni correction, in which basal TNFAIP3 expression, *p < 0.05, or C. acnes-induced TNFAIP3 expression, 
#p < 0.05, were compared. (G, H) OS cultures were treated with 3×107 bacterium/cm2 for 24 h. The epidermis was separated by dispase digestion and 
the mRNA expression was analysed only in epidermal cells by real-time RT-PCR. Protein expression was visualized using immunofluorescence staining 
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protein levels (Fig. 3A). The effect of TNFAIP3 on NF-κB 
activity was then analysed using a luciferase reporter as-
say. In these samples, the basal NF-κB promoter activity 
increased significantly, compared with the scrambled-
siRNA (scr-siRNA) transfected controls (Fig. 3B).
The consequences of these events was also monitored, 
and it was found that TNFAIP3 silencing significantly 
increased the basal mRNA expression of TNFα, inter-
leukin (IL)-1α, IL-6, IL-8 and C-C motif chemokine 
ligand 5 (CCL5) and the secreted levels of IL-6 and IL8, 
compared with the scr-siRNA control samples. These data 
suggest that TNFAIP3 may have important roles in the 
establishment and maintenance of keratinocyte cellular 
homeostasis by controlling the constitutive expression of 
different key inflammatory mediators.
The effect of TNFAIP3 knockdown on C. acnes-induced 
levels of IL-6, IL8 and CCL5 were also investigated, and 
it was found that silencing also significantly increased the 
levels of mRNA and secreted protein (Fig. 3C, D).
TNFAIP3 expression differs in acne lesions
C. acnes may play important roles in the regulation and 
maintenance of epidermal homeostasis, as well as in 
Fig. 3. Tumour necrosis factor alpha-induced protein 3 (TNFAIP3) negatively regulates downstream targets of toll-like receptor (TLR) 
signalling pathways. Transient siRNA-mediated silencing was performed for 48 h in human immortalized keratinocyte cell line (HPV-KER) cells. (A) 
TNFAIP3 protein levels were analysed by western blot analysis and quantified using Image Pro Plus (Media Cybernetics, Inc., Rockville, MD, USA). All 
data were normalized to actin. Error bars: standard deviation (SD). (B) Nuclear factor kappa B (NF-κB) promoter activity was measured with luciferase 
reporter assay, for which all data were normalized to Renilla and compared with src-siRNA containing samples. Error bars: standard error of the mean 
(SEM). Statistical analysis paired, 2-sample t-test: *p < 0.05. (C) After silencing, cells were treated with C. acnes for 6 h and basal and bacterium-induced 
mRNA expression of tumour necrosis factor alpha (TNFα), interleukin (IL)-1α, IL-6, IL-8 and C-C motif chemokine ligand 5 (CCL5) were monitored 
by real time RT-PCR. All data were normalized to 18S rRNA and compared with untreated scr-siRNA containing samples. Error bars: SEM. Statistical 
analyses: paired Student’s t-test with Holm–Bonferroni correction, *p < 0.05. (D) After silencing, cells were treated with C. acnes for 24 h and secreted 
IL-6, IL-8 and CCL5 proteins were measured by enzyme-linked immunoassay (ELISA). Error bars: SEM. Statistical analysis: paired Student’s t-test with 
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acne vulgaris pathogenesis as an opportunistic pathogen 
because of bacterial dysbiosis. To determine whether 
levels of tissue TNFAIP3 differ in healthy and lesional 
skin samples, data from a publicly available GEO Profile 
dataset were analysed, comparing the total RNA content 
of healthy individuals with lesional and non-lesional skin 
samples of patients with acne (18). Significantly increased 
levels of TNFAIP3 mRNA expression were found in 
lesion al skin samples compared with non-lesional skin 
of patients with acne (Fig. 4).
DISCUSSION
The cutaneous microbiota plays important roles in the 
maintenance of epidermal homeostasis. It protects against 
pathogenic microbes, promotes cell differentiation in the 
host, and keeps the immune system in an alert state, ready 
to mount a rapid response to repel pathogenic attacks (2, 7). 
These functions require balanced interactions among the 
human cells and the microbes. When this balance shifts, 
microbial dysbiosis may occur, resulting in pathogenesis 
that manifests as skin disease, such as Malassezia spp in se-
borrhoeic dermatitis, S. aureus and S. epidermidis in atopic 
dermatitis (AD) and C. acnes in acne vulgaris (24, 25).
Research efforts in the last few decades clearly indicate 
that epidermal keratinocytes are immunocompetent cells 
(4, 26, 27). They are equipped to recognize external micro-
bes, mount immediate and efficient responses to maintain 
the integrity of the organism, and alert the immune system 
to harm. Interestingly, both pathogens and members of the 
skin microbiota are able to initiate this internal danger pro-
gramme in keratinocytes, and induce innate immune and 
inflammatory events in these cells through the expression 
of PRRs, such as TLRs (28). However, these microbes are 
constantly present in the skin, and, therefore, microbiota-
induced immune activations must be tightly regulated to 
avoid unnecessary inflammation and to maintain skin 
homeostasis. In past decades, several negative regulators 
of the TLR and NF-κB signalling pathways have been 
identified, including TNFAIP3 (5).
TNFAIP3, also known as A20, is a ubiquitin editing 
enzyme. Through its zinc finger domains, ubiquitin 
ligase and deubiquitinase activity, TNFAIP3 controls 
TNF receptors (TNFR) and TLR pathways at different 
levels (29). TNFAIP3 acts directly on receptor interac-
ting protein (RIP) 1 and NF-kappa-B essential modifier 
(NEMO), which dampen downstream signalling cascades. 
TNFAIP3 also controls ubiquitin-conjugating enzyme E2 
N (UBE2N) and cellular inhibitor of apoptosis proteins 1 
and 2 (cIAP1/2) enzymes complexes by destabilizing their 
interaction. This protein also accelerates the dissociation 
of linear ubiquitin chain assembly complex (LUBAC) and 
inhibitory kappa B kinases (IKK)/NEMO, leading to the 
termination of NF-κB activation (30). 
Tight regulation of TNFAIP3 is important for the 
maintenance of cellular homeostasis. In a murine model, 
cell-specific deletion of the TNFAIP3 gene in various cells 
with important innate and adaptive immune functions re-
sulted in spontaneous development of inflammation (30, 
31). In corroboration with these results, polymorphisms 
within and near the TNFAIP3 locus have been shown to 
be associated with different autoimmune and chronic in-
flammatory diseases, including psoriasis (PsO), systemic 
lupus erythematosus, multiple sclerosis and rheumatoid 
arthritis (32–35). 
In agreement with other studies (21), the current study 
found that TNFAIP3 is expressed through the entire epi-
dermis, exhibiting higher levels in the more differentiated 
keratinocyte layers. This gradient may be formed in pa-
rallel with natural differentiation processes, as one of the 
major regulators of keratinocyte differentiation is calcium 
(Ca2+) and, together with Ca2+-induced differentiation, 
TNFAIP3 expression also increases in in vitro cultured 
normal human keratinocytes (21, 36). The molecular 
details of these events are currently unknown, but it may 
be mediated through the DREAM transcription factor, 
which is Ca2+ regulated and also plays important roles in 
the regulation of TNFAIP3 transcription (22, 37). 
To analyse the role of TNFAIP3 in the regulation of 
innate immune and inflammatory events in keratinocytes, 
different TLRs (1/2, 2, 3, 4, 5 and 2/6) were activated by 
challenging HPV-KER cells with well-known PAMPs 
(Pam3CSK4, PGN, poly I:C, LPS, FLA and FSL-1) and 
changes in TNFAIP3 expression were analysed. All of the 
investigated TLR ligands increased both the mRNA and 
protein expression levels of TNFAIP3 in HPV-KER cells; 
however, the extent of the changes and the time-kinetics 
were ligand-dependent. These data are in agreement with 
previous findings with different cell types, suggesting that 
TNFAIP3 is a generally expressed, universal regulator of 
the TLR signalling pathways.
Based on these results, the current study aimed to in-
vestigate whether TNFAIP3 also plays a role in C. acnes- 
induced immune and inflammatory events in human 
Fig. 4. mRNA expression profile of tumour necrosis factor alpha-
induced protein 3 (TNFAIP3) in healthy skin and skin from patients 
with acne. TNFAIP3 expression profile from GEO Profile data were 
analysed and compared with paired Student’s t-test with Holm–Bonferroni 
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keratinocytes. First, it was checked whether the bacterium 
itself influences TNFAIP3 expression in vitro and ex vivo. 
The results showed that both the mRNA and protein ex-
pression increased rapidly in a dose-dependent manner 
in response to C. acnes in cultured HPV-KER cells as 
well as in the epidermal part of an ex vivo skin model. A 
similar effect was described recently for another member 
of the skin microbiota, S. epidermidis (13). These results, 
taken together, indicate that the TNFAIP3 protein may 
play important roles in the regulation of immune and 
inflammation activation in response to various members 
of the cutaneous microbiota. 
 C. acnes is one of the most prominent cutaneous 
microb es in the sebum-rich skin regions from adoles-
cence, and plays a role in the pathogenesis of acne vul-
garis as a result of microbial dysbiosis (24). In order to 
determine whether TNFAIP3 levels differ in control indi-
viduals and lesional and non-lesional skin samples from 
patients with acne, the current study compared publicly 
available microarray data in the GEO Profile database (ID: 
33444972) and found that, in patients, mRNA expression 
of TNFAIP3 increases significantly in papules compared 
with non-lesional skin samples from the same patients. 
These results suggest that, in the lesional skin, apart from 
the production of different pro-inflammatory mediators, 
expression of anti-inflammatory molecules also increases. 
These latter molecules may play important roles in control 
of inflammation, to avoid excessive, potentially tissue-
damaging reactions. Further research is necessary to 
determine whether increased TNFAIP3 mRNA levels in 
the lesional skin correspond to elevated protein levels. If 
mRNA and protein levels correspond, the accumulation 
may be an important step during the healing of lesions 
and the restoration of epidermal homeostasis.
Interestingly, acne is not the only inflammatory skin 
disease in which TNFAIP3 levels change. In PsO and 
AD, studies have found lower TNFAIP3 mRNA levels in 
lesional skin samples, compared with skin from healthy 
individuals. Moreover, in patients with PsO, TNFAIP3 
mRNA and protein levels were lower in lesional skin 
than in non-lesional samples of the same patients. In 
contrast, TNFAIP3 mRNA expression levels in patients 
with atopic dermatitis (AD) did not differ in the involved 
and non-involved samples (21, 38). It is not clear whether 
this observation represents a true difference in the pat-
hogenesis of these chronic inflammatory skin conditions. 
One possible explanation is that the levels of negative 
regulators may change rapidly throughout the different 
phases of disease pathogenesis, and the above observa-
tions represent only temporal variations. It is interesting 
to note, however, that inability to control innate immune 
activation due to decreased TNFAIP3 levels may lead to 
persisting, chronic inflammation, and the net outcome 
and the severity of inflammation possibly depends on the 
balance of pro- and anti-inflammatory factors. As a result, 
this molecule may serve as a drug target for treatment in 
the future. 
Previous studies have found differences in the compo-
sition of C. acnes strains in healthy and acne skin (39), 
and various strains may differently affect the cellular and 
molecular biology functions as well as keratinocyte viabi-
lity (16, 20, 40, 41). Slight differences were found in the 
TNFAIP3 mRNA expression levels when the HPV-KER 
cells were co-cultured with different C. acnes strains (889, 
ATCC11828, 6609), but the expression kinetics were very 
similar. The C. acnes strains used differ, among others, 
in their growth rate, amount of secreted metabolites (e.g. 
various short-chain fatty acids (SCFAs)), and pathogenic 
factors (e.g. Christie-Atkins-Munch-Peterson (CAMP) 
factors). These properties may be responsible for the ob-
served differences (16, 42). This is similar to the results 
reported previously, in our analysis of a TNFAIP3 inte-
raction partner, TNFAIP3 interacting protein 1 (TNIP1), 
another negative regulator, under similar experimental 
conditions (43). These findings suggest that strain-specific 
biological effects of C. acnes are probably not due to the 
differential induction of various negative regulators upon 
immune and inflammation induction in keratinocytes. 
Multiple signalling pathways and transcriptional factors 
are involved in the transcriptional regulation of TNFAIP3. 
In LPS-activated bone-marrow-derived macrophages 
from mice, NF-κB and p38 regulate TNFAIP3 expression 
through its NF-κB and CCAAT-enhancer-binding protein 
(C/EBPβ) binding sites (23). However, in Pam3CSK4-
activated THP1 cells, NF-κB inhibition has no effect: 
GSK3-related pathways regulate changes in TNFAIP3 
expression, possibly through the cAMP response element 
binding protein (CREB) (44). Others also showed that 
the DREAM complex represses its transcriptional acti-
vation through downstream-responsive elements (DRE3 
and DRE4) binding sites in mice and HLMVECs (22). 
These findings suggest that transcriptional regulation of 
TNFAIP3 is possibly dependent on the type of cell and 
stimuli. We found that the basal mRNA expression of 
TNFAIP3 is regulated by JNK, whereas JNK and NF-
κB signalling pathways are involved in the control of 
C. acnes-induced changes in TNFAIP3 mRNA and protein 
expression, for which p38 and ERK1/2 inhibition had 
no effect. Dual inhibition of JNK and NF-κB signalling 
pathways almost completely inhibited C. acnes-induced 
changes in mRNA expression, which suggest that these 
2 signalling pathways have a major impact on the bac-
terium-induced regulation of TNFAIP3 mRNA levels in 
HPV-KER cells.
A recent study suggested that TNFAIP3 may help S. epi-
dermidis to persist as a commensal on the human skin, th-
rough the control of bacterium-induced NF-κB activation, 
IL-1β and human beta-defensin-2 (HBD-2) production in 
keratinocytes (13). Based on these findings, the current 
study aimed to determine whether this negative regulatory 
function also occurs in C. acnes-induced inflammatory 
processes. In these experiments, silencing TNFAIP3 
significantly increased basal NF-κB promoter activities, 
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cytokines and chemokines (TNFα, IL-1α, IL-6, IL-8 
and CCL5) in HPV-KER cells. Co-culturing of silenced 
cells with the C. acnes 889 strain also leads to increased 
TNFα, IL-1α, IL-6, IL-8 and CCL5 mRNA expression, as 
well as elevated IL-8, IL-6 and CCL5 protein secretions. 
These data argue that TNFAIP3 plays important roles 
in the regulation of C. acnes-driven molecular events in 
keratinocytes, as well as in the maintenance of cellular 
homeostasis, by regulating the cutaneous inflammatory 
programme under homeostatic conditions (45). 
TNFAIP3 possibly operates in a negative regula-
tory cycle in keratinocytes (Fig. 5). In this control loop, 
TNFAIP3 regulates the signalling consequences of a broad 
spectrum of TLR ligands, which, in turn, also affects 
TNFAIP3 levels. This is in agreement with the currently 
available research data, suggesting TNFAIP3 functions 
in, for example, poly-I:C-induced inflammatory responses 
in human keratinocytes, as well as in imiquimod- and 
acetone-induced PsO and dermatitis in mouse models, 
respectively (21, 38). TNFAIP3 also plays important roles 
in the induction of Pam3CSK4-tolerance in monocytic 
THP-1 cells, arguing for a generalized role for this mole-
cule in different TLR-mediated molecular processes (44). 
In summary, TNFAIP3 plays important roles in the re-
gulation of TLR-induced signalling pathways in keratino-
cytes, and, through these roles, contributes to the control 
of C. acnes-induced innate immune and inflammatory 
events. By fine-tuning the microbiota-induced signalling 
processes, TNFAIP3 may help to maintain a homeostatic 
condition between the skin and the cutaneous microflora.
Currently, several different therapeutic modalities are 
available for the treatment of acne vulgaris. They may 
be clinically effective, although all of them only treat 
an existing condition, and most of them have substantial 
side-effects (e.g. antibiotics, retinoids) (46, 47). Targeting 
negative regulators of the C. acnes-induced inflammatory 
pathways themselves may help to develop novel, well-
tolerated therapeutic modalities for the treatment of acne 
vulgaris. Further studies should evaluate the potential use 
and efficacy of TNFAIP3 as such a target.
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